Log in

OTCMKTS:HGENHumanigen Stock Price, Forecast & News

$1.08
-0.07 (-6.09 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.07
Now: $1.08
$1.20
50-Day Range
$0.33
MA: $0.64
$1.35
52-Week Range
$0.30
Now: $1.08
$2.04
Volume39,452 shs
Average Volume61,191 shs
Market Capitalization$123.44 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.25
Humanigen, Inc., a biopharmaceutical company, engages in developing its proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's products include lenzilumab and ifabotuzumab, which are monoclonal antibodies derived from Humaneered platform. Lenzilumab targets granulocyte-macrophage colony-stimulating factor (GM-CSF), and is in development as a potential medicine for chimeric antigen receptor T cell (CAR-T) therapy, as well as a potential treatment for rare hematologic cancers, such as chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML). Ifabotuzumab targets Ephrin type-A receptor 3 (EphA3), and is being explored as a potential treatment for glioblastoma multiforme (GBM) and other cancers, as well as for use in novel CAR-T construct and bispecific antibody platform. The company was formerly known as KaloBios Pharmaceuticals, Inc. and changed its name to Humanigen, Inc. in August 2017. Humanigen, Inc. was founded in 2000 and is based in Burlingame, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HGEN
Previous SymbolNASDAQ:KBIO
CUSIPN/A
Phone650-243-3100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.13) per share

Profitability

Net Income$-10,290,000.00

Miscellaneous

Employees3
Market Cap$123.44 million
Next Earnings Date5/1/2020 (Estimated)
OptionableNot Optionable

Receive HGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter.


Humanigen (OTCMKTS:HGEN) Frequently Asked Questions

How has Humanigen's stock been impacted by COVID-19 (Coronavirus)?

Humanigen's stock was trading at $0.65 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HGEN shares have increased by 66.2% and is now trading at $1.08. View which stocks have been mosted impacted by Coronavirus.

When is Humanigen's next earnings date?

Humanigen is scheduled to release its next quarterly earnings announcement on Friday, May 1st 2020. View our earnings forecast for Humanigen.

How were Humanigen's earnings last quarter?

Humanigen Inc (OTCMKTS:HGEN) posted its quarterly earnings results on Thursday, November, 10th. The company reported ($0.30) EPS for the quarter. View Humanigen's earnings history.

Has Humanigen been receiving favorable news coverage?

News coverage about HGEN stock has trended very negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Humanigen earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutHumanigen.

Who are some of Humanigen's key competitors?

What other stocks do shareholders of Humanigen own?

Who are Humanigen's key executives?

Humanigen's management team includes the following people:
  • Dr. Cameron Durrant M.B.A., M.D., MBA, Chairman & CEO (Age 59)
  • Mr. J. Gregory Jester, Chief Financial Officer (Age 51)
  • Mr. Christopher Bowe, Head of Corp. Affairs
  • Dr. Tarek Sahmoud, Chief Medical Officer

What is Humanigen's stock symbol?

Humanigen trades on the OTCMKTS under the ticker symbol "HGEN."

How do I buy shares of Humanigen?

Shares of HGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Humanigen's stock price today?

One share of HGEN stock can currently be purchased for approximately $1.08.

How big of a company is Humanigen?

Humanigen has a market capitalization of $123.44 million. Humanigen employs 3 workers across the globe. View additional information about Humanigen.

What is Humanigen's official website?

The official website for Humanigen is http://www.humanigen.com/.

How can I contact Humanigen?

Humanigen's mailing address is 533 Airport Boulevard Ste. 400, Burlingame CA, 94005. The company can be reached via phone at 650-243-3100 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: Marijuana Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel